Axis Capital (AXS) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
AXSM advances AXS-12 toward potential approval after the FDA accepts its NDA for cataplexy in narcolepsy and sets a May 2027 decision date.
Axis Capital (AXS) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
AXIS Capital's specialty insurance strength, premium growth and underwriting profitability support growth, while currency exposure and economic uncertainty remain concerns.
Axis Capital (AXS) reported earnings 30 days ago. What's next for the stock?
AXIS Capital targets growth in specialty insurance and reinsurance while boosting investment income and shareholder returns.
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
AXIS Capital Holdings common stock remains unappealing due to persistent underperformance versus peers and modest forward growth expectations. AXS.PR.E preferred shares offer a 6.99% yield, are investment grade, and appear undervalued relative to both company debt and sector peers. Strong dividend coverage, stable capital structure, and recent $300M share repurchase authorization enhance preferred dividend safety and investor confidence.
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
AXS beats Q1 estimates as underwriting income climbs and premiums grow, offsetting weaker investment income and higher expenses.
AXIS Capital Holdings Limited (AXS) Q1 2026 Earnings Call Transcript